APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chagas Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chagas Disease Treatment Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchChagas Disease Treatment Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Chagas Disease Treatment Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Chagas Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chagas Disease Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Chagas Disease Treatment Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Chagas Disease Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chagas Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chagas Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chagas Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chagas Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chagas Disease Treatment include Daiichi Sankyo Company Ltd, Eisai Co Ltd, ELEA SACIF Laboratory, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Grupo Praxis Pharmaceutical SA, KaloBios Pharmaceuticals, Inc, Kancera AB and Laboratorio Elea Phoenix SA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chagas Disease Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chagas Disease Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Chagas Disease Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chagas Disease Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chagas Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chagas Disease Treatment sales, projected growth trends, production technology, application and end-user industry.

Chagas Disease Treatment Segment by Company

Daiichi Sankyo Company Ltd

Eisai Co Ltd

ELEA SACIF Laboratory

F. Hoffmann-La Roche Ltd.

GlaxoSmithKline Plc

Grupo Praxis Pharmaceutical SA

KaloBios Pharmaceuticals, Inc

Kancera AB

Laboratorio Elea Phoenix SA

Laboratorio Farmaceutico De Pernambuco

Maprimed S.A

Nortec Quimica SA

Novartis AG

Oblita Therapeutics BVBA

Sanofi Aventis

AstraZeneca

Bayer AG

Johnson & Johnson

Chagas Disease Treatment Segment by Type

Benznidazole

Nifurtimox

Chagas Disease Treatment Segment by Application

Hospitals

Online Pharmacies

Retail Pharmacies

Chagas Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chagas Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chagas Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chagas Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chagas Disease Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chagas Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chagas Disease Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chagas Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benznidazole Major Manufacturers Table 3. Nifurtimox Major Manufacturers Table 4. Global Chagas Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. Chagas Disease Treatment Industry Trends Table 9. Chagas Disease Treatment Industry Drivers Table 10. Chagas Disease Treatment Industry Opportunities and Challenges Table 11. Chagas Disease Treatment Industry Restraints Table 12. Global Chagas Disease Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Chagas Disease Treatment Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Chagas Disease Treatment Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Chagas Disease Treatment Revenue Market Share by Region (2021-2026) Table 16. Global Chagas Disease Treatment Revenue Market Share by Region (2027-2032) Table 17. Global Chagas Disease Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Chagas Disease Treatment Sales by Region (2021-2026) & (k units) Table 19. Global Chagas Disease Treatment Sales by Region (2027-2032) & (k units) Table 20. Global Chagas Disease Treatment Sales Market Share by Region (2021-2026) Table 21. Global Chagas Disease Treatment Sales Market Share by Region (2027-2032) Table 22. Global Chagas Disease Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Chagas Disease Treatment Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Chagas Disease Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Chagas Disease Treatment Sales Market Share by Manufacturers (2021-2026) Table 26. Global Chagas Disease Treatment Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Chagas Disease Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Chagas Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Chagas Disease Treatment Manufacturers, Product Type & Application Table 30. Global Chagas Disease Treatment Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Chagas Disease Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Chagas Disease Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Chagas Disease Treatment Revenue Market Share by Type (2021-2026) Table 37. Global Chagas Disease Treatment Revenue Market Share by Type (2027-2032) Table 38. Global Chagas Disease Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 40. Global Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 41. Global Chagas Disease Treatment Sales Market Share by Type (2021-2026) Table 42. Global Chagas Disease Treatment Sales Market Share by Type (2027-2032) Table 43. Global Chagas Disease Treatment Price by Type (2021-2026) & (US$/unit) Table 44. Global Chagas Disease Treatment Price by Type (2027-2032) & (US$/unit) Table 45. Global Chagas Disease Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Chagas Disease Treatment Revenue Market Share by Application (2021-2026) Table 49. Global Chagas Disease Treatment Revenue Market Share by Application (2027-2032) Table 50. Global Chagas Disease Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 52. Global Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 53. Global Chagas Disease Treatment Sales Market Share by Application (2021-2026) Table 54. Global Chagas Disease Treatment Sales Market Share by Application (2027-2032) Table 55. Global Chagas Disease Treatment Price by Application (2021-2026) & (US$/unit) Table 56. Global Chagas Disease Treatment Price by Application (2027-2032) & (US$/unit) Table 57. Daiichi Sankyo Company Ltd Company Information Table 58. Daiichi Sankyo Company Ltd Business Overview Table 59. Daiichi Sankyo Company Ltd Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Daiichi Sankyo Company Ltd Chagas Disease Treatment Product Portfolio Table 61. Daiichi Sankyo Company Ltd Recent Development Table 62. Eisai Co Ltd Company Information Table 63. Eisai Co Ltd Business Overview Table 64. Eisai Co Ltd Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Eisai Co Ltd Chagas Disease Treatment Product Portfolio Table 66. Eisai Co Ltd Recent Development Table 67. ELEA SACIF Laboratory Company Information Table 68. ELEA SACIF Laboratory Business Overview Table 69. ELEA SACIF Laboratory Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. ELEA SACIF Laboratory Chagas Disease Treatment Product Portfolio Table 71. ELEA SACIF Laboratory Recent Development Table 72. F. Hoffmann-La Roche Ltd. Company Information Table 73. F. Hoffmann-La Roche Ltd. Business Overview Table 74. F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Product Portfolio Table 76. F. Hoffmann-La Roche Ltd. Recent Development Table 77. GlaxoSmithKline Plc Company Information Table 78. GlaxoSmithKline Plc Business Overview Table 79. GlaxoSmithKline Plc Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Plc Chagas Disease Treatment Product Portfolio Table 81. GlaxoSmithKline Plc Recent Development Table 82. Grupo Praxis Pharmaceutical SA Company Information Table 83. Grupo Praxis Pharmaceutical SA Business Overview Table 84. Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Product Portfolio Table 86. Grupo Praxis Pharmaceutical SA Recent Development Table 87. KaloBios Pharmaceuticals, Inc Company Information Table 88. KaloBios Pharmaceuticals, Inc Business Overview Table 89. KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Product Portfolio Table 91. KaloBios Pharmaceuticals, Inc Recent Development Table 92. Kancera AB Company Information Table 93. Kancera AB Business Overview Table 94. Kancera AB Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Kancera AB Chagas Disease Treatment Product Portfolio Table 96. Kancera AB Recent Development Table 97. Laboratorio Elea Phoenix SA Company Information Table 98. Laboratorio Elea Phoenix SA Business Overview Table 99. Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Portfolio Table 101. Laboratorio Elea Phoenix SA Recent Development Table 102. Laboratorio Farmaceutico De Pernambuco Company Information Table 103. Laboratorio Farmaceutico De Pernambuco Business Overview Table 104. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Portfolio Table 106. Laboratorio Farmaceutico De Pernambuco Recent Development Table 107. Maprimed S.A Company Information Table 108. Maprimed S.A Business Overview Table 109. Maprimed S.A Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Maprimed S.A Chagas Disease Treatment Product Portfolio Table 111. Maprimed S.A Recent Development Table 112. Nortec Quimica SA Company Information Table 113. Nortec Quimica SA Business Overview Table 114. Nortec Quimica SA Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Nortec Quimica SA Chagas Disease Treatment Product Portfolio Table 116. Nortec Quimica SA Recent Development Table 117. Novartis AG Company Information Table 118. Novartis AG Business Overview Table 119. Novartis AG Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Novartis AG Chagas Disease Treatment Product Portfolio Table 121. Novartis AG Recent Development Table 122. Oblita Therapeutics BVBA Company Information Table 123. Oblita Therapeutics BVBA Business Overview Table 124. Oblita Therapeutics BVBA Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Oblita Therapeutics BVBA Chagas Disease Treatment Product Portfolio Table 126. Oblita Therapeutics BVBA Recent Development Table 127. Sanofi Aventis Company Information Table 128. Sanofi Aventis Business Overview Table 129. Sanofi Aventis Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Sanofi Aventis Chagas Disease Treatment Product Portfolio Table 131. Sanofi Aventis Recent Development Table 132. AstraZeneca Company Information Table 133. AstraZeneca Business Overview Table 134. AstraZeneca Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. AstraZeneca Chagas Disease Treatment Product Portfolio Table 136. AstraZeneca Recent Development Table 137. Bayer AG Company Information Table 138. Bayer AG Business Overview Table 139. Bayer AG Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Bayer AG Chagas Disease Treatment Product Portfolio Table 141. Bayer AG Recent Development Table 142. Johnson & Johnson Company Information Table 143. Johnson & Johnson Business Overview Table 144. Johnson & Johnson Chagas Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Johnson & Johnson Chagas Disease Treatment Product Portfolio Table 146. Johnson & Johnson Recent Development Table 147. North America Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 150. North America Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 151. North America Chagas Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 152. North America Chagas Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 153. North America Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 156. North America Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 157. North America Chagas Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 158. North America Chagas Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 159. North America Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Chagas Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Chagas Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. North America Chagas Disease Treatment Sales by Country (2021-2026) & (k units) Table 164. North America Chagas Disease Treatment Sales by Country (2027-2032) & (k units) Table 165. North America Chagas Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 166. North America Chagas Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 167. United States Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 168. Canada Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 169. Mexico Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 170. Europe Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 173. Europe Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 174. Europe Chagas Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 175. Europe Chagas Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 176. Europe Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 179. Europe Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 180. Europe Chagas Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 181. Europe Chagas Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 182. Europe Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Chagas Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Chagas Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Europe Chagas Disease Treatment Sales by Country (2021-2026) & (k units) Table 187. Europe Chagas Disease Treatment Sales by Country (2027-2032) & (k units) Table 188. Europe Chagas Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 189. Europe Chagas Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 190. Germany Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 191. France Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 192. U.K. Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 193. Italy Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 194. Russia Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 195. Spain Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 198. Sweden Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 199. Poland Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 200. China Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 201. China Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 202. China Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 203. China Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 204. China Chagas Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 205. China Chagas Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 206. China Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 207. China Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 208. China Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 209. China Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 210. China Chagas Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 211. China Chagas Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 212. Asia Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 215. Asia Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 216. Asia Chagas Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 217. Asia Chagas Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 218. Asia Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 221. Asia Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 222. Asia Chagas Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 223. Asia Chagas Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 224. Asia Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Chagas Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Chagas Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. Asia Chagas Disease Treatment Sales by Country (2021-2026) & (k units) Table 229. Asia Chagas Disease Treatment Sales by Country (2027-2032) & (k units) Table 230. Asia Chagas Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 231. Asia Chagas Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 232. Japan Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 233. South Korea Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 234. India Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 235. Australia Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Chagas Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Chagas Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Chagas Disease Treatment Sales by Type (2021-2026) & (k units) Table 241. SAMEA Chagas Disease Treatment Sales by Type (2027-2032) & (k units) Table 242. SAMEA Chagas Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 243. SAMEA Chagas Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 244. SAMEA Chagas Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Chagas Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Chagas Disease Treatment Sales by Application (2021-2026) & (k units) Table 247. SAMEA Chagas Disease Treatment Sales by Application (2027-2032) & (k units) Table 248. SAMEA Chagas Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 249. SAMEA Chagas Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 250. SAMEA Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Chagas Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Chagas Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. SAMEA Chagas Disease Treatment Sales by Country (2021-2026) & (k units) Table 255. SAMEA Chagas Disease Treatment Sales by Country (2027-2032) & (k units) Table 256. SAMEA Chagas Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 257. SAMEA Chagas Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 258. Brazil Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 259. Argentina Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 260. Chile Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 261. Colombia Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 262. Peru Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 264. Israel Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 265. UAE Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 266. Turkey Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 267. Iran Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 268. Egypt Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Chagas Disease Treatment Distributors List Table 272. Chagas Disease Treatment Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Chagas Disease Treatment Image Figure 2. Global Chagas Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chagas Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Benznidazole Image Figure 5. Nifurtimox Image Figure 6. Global Chagas Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chagas Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Online Pharmacies Image Figure 10. Retail Pharmacies Image Figure 11. Global Chagas Disease Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Chagas Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 13. Global Chagas Disease Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Chagas Disease Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Chagas Disease Treatment Revenue Market Share by Region (2021-2032) Figure 16. Global Chagas Disease Treatment Sales (2021-2032) & (k units) Figure 17. Global Chagas Disease Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Chagas Disease Treatment Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Chagas Disease Treatment Sales YoY (2021-2032) & (k units) Figure 20. Europe Chagas Disease Treatment Sales YoY (2021-2032) & (k units) Figure 21. China Chagas Disease Treatment Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Chagas Disease Treatment Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Chagas Disease Treatment Sales YoY (2021-2032) & (k units) Figure 24. Global Chagas Disease Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Chagas Disease Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Chagas Disease Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Chagas Disease Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Chagas Disease Treatment Revenue Market Share by Type (2021-2032) Figure 30. Global Chagas Disease Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Chagas Disease Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Chagas Disease Treatment Sales Market Share by Type (2021-2032) Figure 33. Global Chagas Disease Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Chagas Disease Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Chagas Disease Treatment Revenue Market Share by Application (2021-2032) Figure 36. Global Chagas Disease Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Chagas Disease Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Chagas Disease Treatment Sales Market Share by Application (2021-2032) Figure 39. North America Chagas Disease Treatment Revenue Share by Type (2021-2032) Figure 40. North America Chagas Disease Treatment Sales Share by Type (2021-2032) Figure 41. North America Chagas Disease Treatment Revenue Share by Application (2021-2032) Figure 42. North America Chagas Disease Treatment Sales Share by Application (2021-2032) Figure 43. North America Chagas Disease Treatment Revenue Share by Country (2021-2032) Figure 44. North America Chagas Disease Treatment Sales Share by Country (2021-2032) Figure 45. Europe Chagas Disease Treatment Revenue Share by Type (2021-2032) Figure 46. Europe Chagas Disease Treatment Sales Share by Type (2021-2032) Figure 47. Europe Chagas Disease Treatment Revenue Share by Application (2021-2032) Figure 48. Europe Chagas Disease Treatment Sales Share by Application (2021-2032) Figure 49. Europe Chagas Disease Treatment Revenue Share by Country (2021-2032) Figure 50. Europe Chagas Disease Treatment Sales Share by Country (2021-2032) Figure 51. China Chagas Disease Treatment Revenue Share by Type (2021-2032) Figure 52. China Chagas Disease Treatment Sales Share by Type (2021-2032) Figure 53. China Chagas Disease Treatment Revenue Share by Application (2021-2032) Figure 54. China Chagas Disease Treatment Sales Share by Application (2021-2032) Figure 55. Asia Chagas Disease Treatment Revenue Share by Type (2021-2032) Figure 56. Asia Chagas Disease Treatment Sales Share by Type (2021-2032) Figure 57. Asia Chagas Disease Treatment Revenue Share by Application (2021-2032) Figure 58. Asia Chagas Disease Treatment Sales Share by Application (2021-2032) Figure 59. Asia Chagas Disease Treatment Revenue Share by Country (2021-2032) Figure 60. Asia Chagas Disease Treatment Sales Share by Country (2021-2032) Figure 61. SAMEA Chagas Disease Treatment Revenue Share by Type (2021-2032) Figure 62. SAMEA Chagas Disease Treatment Sales Share by Type (2021-2032) Figure 63. SAMEA Chagas Disease Treatment Revenue Share by Application (2021-2032) Figure 64. SAMEA Chagas Disease Treatment Sales Share by Application (2021-2032) Figure 65. SAMEA Chagas Disease Treatment Revenue Share by Country (2021-2032) Figure 66. SAMEA Chagas Disease Treatment Sales Share by Country (2021-2032) Figure 67. Chagas Disease Treatment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Chagas Disease Treatment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Benznidazole
  • Nifurtimox
Applications
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Daiichi Sankyo Company Ltd
  • Eisai Co Ltd
  • ELEA SACIF Laboratory
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Grupo Praxis Pharmaceutical SA
  • KaloBios Pharmaceuticals, Inc
  • Kancera AB
  • Laboratorio Elea Phoenix SA
  • Laboratorio Farmaceutico De Pernambuco
  • Maprimed S.A
  • Nortec Quimica SA
  • Novartis AG
  • Oblita Therapeutics BVBA
  • Sanofi Aventis
  • AstraZeneca
  • Bayer AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chagas Disease Treatment Market by Type
  3. 1.2.1 Global Chagas Disease Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benznidazole
  5. 1.2.3 Nifurtimox
  6. 1.3 Chagas Disease Treatment Market by Application
  7. 1.3.1 Global Chagas Disease Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Retail Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Chagas Disease Treatment Market Dynamics
  1. 2.1 Chagas Disease Treatment Industry Trends
  2. 2.2 Chagas Disease Treatment Industry Drivers
  3. 2.3 Chagas Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Chagas Disease Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chagas Disease Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chagas Disease Treatment Revenue by Region
  3. 3.2.1 Global Chagas Disease Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chagas Disease Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global Chagas Disease Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global Chagas Disease Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chagas Disease Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chagas Disease Treatment Sales by Region
  9. 3.4.1 Global Chagas Disease Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chagas Disease Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global Chagas Disease Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global Chagas Disease Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chagas Disease Treatment Revenue by Manufacturers
  2. 4.1.1 Global Chagas Disease Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chagas Disease Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chagas Disease Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chagas Disease Treatment Sales by Manufacturers
  6. 4.2.1 Global Chagas Disease Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chagas Disease Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chagas Disease Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chagas Disease Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chagas Disease Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chagas Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chagas Disease Treatment Manufacturers, Product Type & Application
  13. 4.7 Global Chagas Disease Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chagas Disease Treatment Market CR5 and HHI
  16. 4.8.2 2025 Chagas Disease Treatment Tier 1, Tier 2, and Tier 3
5 Chagas Disease Treatment Market by Type
  1. 5.1 Global Chagas Disease Treatment Revenue by Type
  2. 5.1.1 Global Chagas Disease Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chagas Disease Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chagas Disease Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chagas Disease Treatment Sales by Type
  6. 5.2.1 Global Chagas Disease Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chagas Disease Treatment Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Chagas Disease Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chagas Disease Treatment Price by Type
6 Chagas Disease Treatment Market by Application
  1. 6.1 Global Chagas Disease Treatment Revenue by Application
  2. 6.1.1 Global Chagas Disease Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chagas Disease Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chagas Disease Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chagas Disease Treatment Sales by Application
  6. 6.2.1 Global Chagas Disease Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chagas Disease Treatment Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Chagas Disease Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chagas Disease Treatment Price by Application
7 Company Profiles
  1. 7.1 Daiichi Sankyo Company Ltd
  2. 7.1.1 Daiichi Sankyo Company Ltd Company Information
  3. 7.1.2 Daiichi Sankyo Company Ltd Business Overview
  4. 7.1.3 Daiichi Sankyo Company Ltd Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Daiichi Sankyo Company Ltd Chagas Disease Treatment Product Portfolio
  6. 7.1.5 Daiichi Sankyo Company Ltd Recent Developments
  7. 7.2 Eisai Co Ltd
  8. 7.2.1 Eisai Co Ltd Company Information
  9. 7.2.2 Eisai Co Ltd Business Overview
  10. 7.2.3 Eisai Co Ltd Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eisai Co Ltd Chagas Disease Treatment Product Portfolio
  12. 7.2.5 Eisai Co Ltd Recent Developments
  13. 7.3 ELEA SACIF Laboratory
  14. 7.3.1 ELEA SACIF Laboratory Company Information
  15. 7.3.2 ELEA SACIF Laboratory Business Overview
  16. 7.3.3 ELEA SACIF Laboratory Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ELEA SACIF Laboratory Chagas Disease Treatment Product Portfolio
  18. 7.3.5 ELEA SACIF Laboratory Recent Developments
  19. 7.4 F. Hoffmann-La Roche Ltd.
  20. 7.4.1 F. Hoffmann-La Roche Ltd. Company Information
  21. 7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
  22. 7.4.3 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 F. Hoffmann-La Roche Ltd. Chagas Disease Treatment Product Portfolio
  24. 7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
  25. 7.5 GlaxoSmithKline Plc
  26. 7.5.1 GlaxoSmithKline Plc Company Information
  27. 7.5.2 GlaxoSmithKline Plc Business Overview
  28. 7.5.3 GlaxoSmithKline Plc Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Plc Chagas Disease Treatment Product Portfolio
  30. 7.5.5 GlaxoSmithKline Plc Recent Developments
  31. 7.6 Grupo Praxis Pharmaceutical SA
  32. 7.6.1 Grupo Praxis Pharmaceutical SA Company Information
  33. 7.6.2 Grupo Praxis Pharmaceutical SA Business Overview
  34. 7.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Treatment Product Portfolio
  36. 7.6.5 Grupo Praxis Pharmaceutical SA Recent Developments
  37. 7.7 KaloBios Pharmaceuticals, Inc
  38. 7.7.1 KaloBios Pharmaceuticals, Inc Company Information
  39. 7.7.2 KaloBios Pharmaceuticals, Inc Business Overview
  40. 7.7.3 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KaloBios Pharmaceuticals, Inc Chagas Disease Treatment Product Portfolio
  42. 7.7.5 KaloBios Pharmaceuticals, Inc Recent Developments
  43. 7.8 Kancera AB
  44. 7.8.1 Kancera AB Company Information
  45. 7.8.2 Kancera AB Business Overview
  46. 7.8.3 Kancera AB Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kancera AB Chagas Disease Treatment Product Portfolio
  48. 7.8.5 Kancera AB Recent Developments
  49. 7.9 Laboratorio Elea Phoenix SA
  50. 7.9.1 Laboratorio Elea Phoenix SA Company Information
  51. 7.9.2 Laboratorio Elea Phoenix SA Business Overview
  52. 7.9.3 Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Portfolio
  54. 7.9.5 Laboratorio Elea Phoenix SA Recent Developments
  55. 7.10 Laboratorio Farmaceutico De Pernambuco
  56. 7.10.1 Laboratorio Farmaceutico De Pernambuco Company Information
  57. 7.10.2 Laboratorio Farmaceutico De Pernambuco Business Overview
  58. 7.10.3 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Portfolio
  60. 7.10.5 Laboratorio Farmaceutico De Pernambuco Recent Developments
  61. 7.11 Maprimed S.A
  62. 7.11.1 Maprimed S.A Company Information
  63. 7.11.2 Maprimed S.A Business Overview
  64. 7.11.3 Maprimed S.A Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Maprimed S.A Chagas Disease Treatment Product Portfolio
  66. 7.11.5 Maprimed S.A Recent Developments
  67. 7.12 Nortec Quimica SA
  68. 7.12.1 Nortec Quimica SA Company Information
  69. 7.12.2 Nortec Quimica SA Business Overview
  70. 7.12.3 Nortec Quimica SA Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Nortec Quimica SA Chagas Disease Treatment Product Portfolio
  72. 7.12.5 Nortec Quimica SA Recent Developments
  73. 7.13 Novartis AG
  74. 7.13.1 Novartis AG Company Information
  75. 7.13.2 Novartis AG Business Overview
  76. 7.13.3 Novartis AG Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Novartis AG Chagas Disease Treatment Product Portfolio
  78. 7.13.5 Novartis AG Recent Developments
  79. 7.14 Oblita Therapeutics BVBA
  80. 7.14.1 Oblita Therapeutics BVBA Company Information
  81. 7.14.2 Oblita Therapeutics BVBA Business Overview
  82. 7.14.3 Oblita Therapeutics BVBA Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Oblita Therapeutics BVBA Chagas Disease Treatment Product Portfolio
  84. 7.14.5 Oblita Therapeutics BVBA Recent Developments
  85. 7.15 Sanofi Aventis
  86. 7.15.1 Sanofi Aventis Company Information
  87. 7.15.2 Sanofi Aventis Business Overview
  88. 7.15.3 Sanofi Aventis Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sanofi Aventis Chagas Disease Treatment Product Portfolio
  90. 7.15.5 Sanofi Aventis Recent Developments
  91. 7.16 AstraZeneca
  92. 7.16.1 AstraZeneca Company Information
  93. 7.16.2 AstraZeneca Business Overview
  94. 7.16.3 AstraZeneca Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AstraZeneca Chagas Disease Treatment Product Portfolio
  96. 7.16.5 AstraZeneca Recent Developments
  97. 7.17 Bayer AG
  98. 7.17.1 Bayer AG Company Information
  99. 7.17.2 Bayer AG Business Overview
  100. 7.17.3 Bayer AG Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bayer AG Chagas Disease Treatment Product Portfolio
  102. 7.17.5 Bayer AG Recent Developments
  103. 7.18 Johnson & Johnson
  104. 7.18.1 Johnson & Johnson Company Information
  105. 7.18.2 Johnson & Johnson Business Overview
  106. 7.18.3 Johnson & Johnson Chagas Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Johnson & Johnson Chagas Disease Treatment Product Portfolio
  108. 7.18.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Chagas Disease Treatment Market Size by Type
  2. 8.1.1 North America Chagas Disease Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America Chagas Disease Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America Chagas Disease Treatment Price by Type (2021-2032)
  5. 8.2 North America Chagas Disease Treatment Market Size by Application
  6. 8.2.1 North America Chagas Disease Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America Chagas Disease Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America Chagas Disease Treatment Price by Application (2021-2032)
  9. 8.3 North America Chagas Disease Treatment Market Size by Country
  10. 8.3.1 North America Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chagas Disease Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Chagas Disease Treatment Market Size by Type
  2. 9.1.1 Europe Chagas Disease Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chagas Disease Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe Chagas Disease Treatment Price by Type (2021-2032)
  5. 9.2 Europe Chagas Disease Treatment Market Size by Application
  6. 9.2.1 Europe Chagas Disease Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chagas Disease Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe Chagas Disease Treatment Price by Application (2021-2032)
  9. 9.3 Europe Chagas Disease Treatment Market Size by Country
  10. 9.3.1 Europe Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chagas Disease Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Chagas Disease Treatment Market Size by Type
  2. 10.1.1 China Chagas Disease Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China Chagas Disease Treatment Sales by Type (2021-2032)
  4. 10.1.3 China Chagas Disease Treatment Price by Type (2021-2032)
  5. 10.2 China Chagas Disease Treatment Market Size by Application
  6. 10.2.1 China Chagas Disease Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China Chagas Disease Treatment Sales by Application (2021-2032)
  8. 10.2.3 China Chagas Disease Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chagas Disease Treatment Market Size by Type
  2. 11.1.1 Asia Chagas Disease Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chagas Disease Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia Chagas Disease Treatment Price by Type (2021-2032)
  5. 11.2 Asia Chagas Disease Treatment Market Size by Application
  6. 11.2.1 Asia Chagas Disease Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chagas Disease Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia Chagas Disease Treatment Price by Application (2021-2032)
  9. 11.3 Asia Chagas Disease Treatment Market Size by Country
  10. 11.3.1 Asia Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chagas Disease Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chagas Disease Treatment Market Size by Type
  2. 12.1.1 SAMEA Chagas Disease Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chagas Disease Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chagas Disease Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA Chagas Disease Treatment Market Size by Application
  6. 12.2.1 SAMEA Chagas Disease Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chagas Disease Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chagas Disease Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA Chagas Disease Treatment Market Size by Country
  10. 12.3.1 SAMEA Chagas Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chagas Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chagas Disease Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chagas Disease Treatment Value Chain Analysis
  2. 13.1.1 Chagas Disease Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chagas Disease Treatment Production Mode & Process
  6. 13.2 Chagas Disease Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chagas Disease Treatment Distributors
  9. 13.2.3 Chagas Disease Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst